RecallDepth
Class III Terminated

Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in a) 90-count bottles (NDC 68180-249-09 and b) 500-count bottles (NDC 68180-249-02); Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Pithampur (M.P.)-454 775, INDIA

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
December 10, 2019
Posted
December 25, 2019
Recall Number
D-0629-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
3,726 bottles
Firm Location
Baltimore, MD, United States

Reason for Recall

Failed Dissolution Specifications: High out of specification result observed at stability studies.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #: H901787, H901788, Exp March 2021

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class III Drug recalls